The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE EVALUATION AND TESTING OF PSYCHOPHARMACEUTIC DRUGS

Published Online:https://doi.org/10.1176/ajp.115.3.232

There is a great current interest in the evaluation and use of psychopharmaceutical agents in the investigation and treatment of mental illness. Clinical investigation of these drugs is made difficult by a number of non-pharmacological factors which can influence the mood and mental status of an individual. The role of the hospital, the patient society, doctor and attendant have been reviewed in order to illustrate their effect on a patient who has become a part of a drug study.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.